Corcept’s cancer drug meets main goal in late-stage trial

Jan 22 (Reuters) – ‍Corcept Therapeutics said ‌on ‌Thursday that its experimental ​cancer ‍drug ​met ​the ‍main goal in ‍a late-stage ‍study.

(Reporting ‍by ​Sahil ​Pandey ⁠in Bengaluru; ‌Editing by Shailesh ⁠Kuber)